Medtronic claims NuVasive infringed on three patents associated with minimally invasive spinal devices and NuVasive alleges that Medtronic Sofamor Danek USA has infringed on its patent for the lateral spine surgery nerve monitoring system. According to the report, Medtronic’s lawyer said the company has calculated a loss of profits of at least $200 million due to the infringement.
The lawyer for NuVasive maintained that the company’s product did not infringe on Medtronic’s patents.
Related Articles on Orthopedic Device Companies:
Successes and Failures: 18 Orthopedic and Spine Device Companies Battling a Tough Market
Wright Medical Group Chief Compliance Officer Resigns
Stryker Takes Mobile Training Center on the Road to China
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.